Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 16.41
+0.05 (0.31%)
May 13, 2025, 2:45 PM CST
SHE:002007 Revenue
Hualan Biological Engineering had revenue of 867.61M CNY in the quarter ending March 31, 2025, with 10.20% growth. This brings the company's revenue in the last twelve months to 4.46B, down -15.03% year-over-year. In the year 2024, Hualan Biological Engineering had annual revenue of 4.38B, down -18.02%.
Revenue (ttm)
4.46B
Revenue Growth
-15.03%
P/S Ratio
6.71
Revenue / Employee
1.11M
Employees
4,012
Market Cap
29.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.38B | -962.68M | -18.02% |
| Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
| Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
| Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
| Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |